Influence of body composition and muscle strength on outcomes after multimodal oesophageal cancer treatment
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index; none of the 50 sources its claims cite is checked for support yet.
Abstract
Background: Influence of sarcopenia in combination with other body composition parameters and muscle strength on outcomes after oesophageal surgery for oesophageal cancer remains unclear. The objectives were (i) to describe the incidence of sarcopenia in relation to adipose tissue quantity and distribution and muscle strength; (ii) to evaluate if neoadjuvant chemoradiation (nCRTx) influences body composition and muscle strength; and (iii) to evaluate the influence of body composition and muscle strength on post‐operative morbidity and long‐term survival. Methods: This retrospective study included patients with oesophageal cancer who received nCRTx followed by surgery between January 2011 and 2016. Skeletal muscle, visceral, and subcutaneous adipose tissue cross‐sectional areas were calculated based on computed tomography scans, and muscle strength was measured using hand grip tests, 30 seconds chair stand tests, and maximal inspiratory and expiratory pressure tests prior to nCRTx and after nCRTx. Results: A total of 322 patients were included in this study. Sarcopenia was present in 55.6% of the patients prior to nCRTx and in 58.2% after nCRTx (P = 0.082). Patients with sarcopenia had a significantly lower muscle strength and higher fat percentage. The muscle strength and incidence of sarcopenia increased while the mean body mass index and fat percentage decreased during nCRTx. A body mass index above 25 kg/m 2 was associated with anastomotic leakage (P = 0.032). Other body composition parameters were not associated with post‐operative morbidity. A lower handgrip strength prior to nCRTx was associated with pulmonary and cardiac complications (P = 0.023 and P = 0.009, respectively). In multivariable analysis, a lower number of stands during the 30 seconds chair stand test prior to nCRTx (hazard ratio 0.93, 95% confidence interval 0.87–0.99, P = 0.017) and visceral adipose tissue of >128 cm 2 after nCRTx (hazard ratio 1.81, 95% confidence interval 1.30–2.53, P = 0.001) were associated with worse overall survival. Conclusions: Sarcopenia occurs frequently in patients with oesophageal cancer and is associated with less muscle strength and a higher fat percentage. Body composition changes during nCRTx did not influence survival. Impaired muscle strength and a high amount of visceral adipose tissue are associated with worse survival. Therefore, patients with poor fitness might benefit from preoperative nutritional and muscle strengthening guidance, aiming to increase muscle strength and decrease visceral adipose tissue. However, this should be confirmed in a large prospective study.
Overview
CoChat Summary
TL;DR
In 322 patients with oesophageal cancer treated with neoadjuvant chemoradiation (nCRTx) and surgery, sarcopenia was common (55.6% before and 58.2% after nCRTx) and associated with lower muscle strength and higher fat percentage, but not with post-operative morbidity or survival. Impaired muscle strength and high visceral adipose tissue after nCRTx were associated with worse overall survival.
Key findings
- Sarcopenia was present in 55.6% of patients prior to nCRTx and 58.2% after nCRTx (P = 0.082). Patients with sarcopenia had significantly lower muscle strength and higher fat percentage; for example, after nCRTx, non-dominant handgrip strength was 37.5 ± 9.7 kg vs 44.6 ± 7.8 kg (P = 0.001), 30 s chair stand test was 16.6 ± 5.6 vs 22.1 ± 8.2 stands (P = 0.001), and fat percentage was 30.6 ± 4.5% vs 29.1 ± 5.4% (P = 0.017).
- During nCRTx, the incidence of sarcopenia increased (55.6–58.2%, P = 0.082) while mean BMI and fat percentage decreased (−0.4 kg/m², 95% CI −0.3 to 0.5, P < 0.001; −0.6%, 95% CI −0.04 to 1.2, P = 0.036). All muscle strength tests increased; the strongest increases were maximal expiratory pressure (mean increase 9.4 cmH₂O, 95% CI 3.7–15.1, P = 0.001) and non-dominant handgrip strength (mean increase 1.4 kg, 95% CI 0.5–2.4, P = 0.004).
- A BMI ≥26 kg/m² prior to nCRTx was associated with anastomotic leakage (15.9% of patients with BMI 18–25 kg/m² vs 26.0% with BMI ≥26 kg/m², P = 0.032). Lower handgrip strength prior to nCRTx was associated with pulmonary and cardiac complications (P = 0.023 and P = 0.009, respectively). Other body composition parameters were not associated with post-operative morbidity.
- In multivariable analysis, a lower number of stands during the 30 s chair stand test prior to nCRTx (HR 0.93, 95% CI 0.87–0.99, P = 0.017) and visceral adipose tissue >128 cm² after nCRTx (HR 1.81, 95% CI 1.30–2.53, P = 0.001) were associated with worse overall survival. Sarcopenia itself was not significantly associated with survival (prior to nCRTx median overall survival 48.4 vs 31.8 months, P = 0.148; after nCRTx 37.6 vs 39.2 months, P = 0.805).
Methods
- Retrospective study using a prospectively maintained database of consecutive patients with oesophageal cancer treated with surgery between 1 January 2011 and 1 January 2016 at Amsterdam UMC (location AMC), the Netherlands. Patients were included if they had resectable oesophageal carcinoma treated with nCRTx followed by surgery; exclusion criteria were missing or insufficient-quality diagnostic CT images before and after nCRTx. A total of 322 patients were included; in 175 patients, both CT scans prior to and after nCRTx were available and eligible for analysis.
- Body composition was assessed from CT scans at the midpoint of the third lumbar vertebra (L3): skeletal muscle, visceral, subcutaneous, and total adipose tissue cross-sectional areas and indexes, presence of sarcopenia, body fat percentage, and BMI. Muscle strength was measured prior to and after nCRTx using hand grip tests, 30 s chair stand tests, and maximal inspiratory and expiratory pressure tests.
- Statistical analysis included descriptive statistics, χ² or Fisher’s exact tests, Wilcoxon signed rank test, independent and dependent t-tests, Kaplan–Meier curves with log-rank tests, and Cox proportional hazard models for multivariable analysis with stepwise backwards elimination (P < 0.05 to stay in the model). Missing data were handled with complete case analysis; analyses used SPSS version 25.0, and two-sided P values <0.05 were considered significant.
Limitations
- Stated in the paper: muscle strength was assessed only in patients also included in another study, and this subgroup was much smaller than the total cohort, which may have contributed to selection bias together with the retrospective design. The incidence of sarcopenic obesity was very low, so its influence on post-operative complications or long-term survival could not be assessed properly. Handgrip strength is less reliable in older patients, and the chair stand test can be influenced by co-morbidities; the cohort had a median age of 65 years and almost half had co-morbidities, which may have made muscle strength outcomes less reliable. No standardized cut-off values for sarcopenia exist; the study used Martin et al. cut-offs, which may differ from the Prado et al. population.
- Evident from the text: this was a single-centre retrospective cohort, and missing data were handled with complete case analysis. Paired CT analyses were limited to 175 of 322 patients who had both pre- and post-nCRTx CT scans available and eligible for analysis.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
0 Valid · 0 Not valid · 32 Not checked · 57 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Sarcopenia was present in 51.4% of the patients with adenocarcinoma and in 71.7% of the patients with squamous cell carcinoma based on the CT scan prior to nCRTx (P = 0.013).”
§ Influence of body composition and muscle strength on outcomes after multimodal oesophageal cancer treatment > Results > Incidence of sarcopenia
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“A BMI of ≥26 kg/m2 prior to nCRTx was associated with a higher incidence of anastomotic leakage (15.9% of the patients with a BMI between 18 and 25 kg/m2 and 26.0% of the patients with a BMI of ≥26 kg/m2 developed anastomotic leakage, P = 0.032).”
- Also stated in: § Results · plain
“A body mass index above 25 kg/m2 was associated with anastomotic leakage (P = 0.032).”
§ Influence of body composition and muscle strength on outcomes after multimodal oesophageal cancer treatment > Results > Influence of body composition and muscle strength on post‐operative complications
plainstates an associationn = 322 ·- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Results · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Sarcopenia was present in 55.6% of the patients prior to nCRTx and in 58.2% after nCRTx (P = 0.082).”
- Also stated in: § Influence of neoadjuvant chemoradiation on body composition and muscle strength · plain
“the incidence of sarcopenia increased (55.6–58.2%, P = 0.082)”
§ Influence of body composition and muscle strength on outcomes after multimodal oesophageal cancer treatment > Abstract > Results
plainn = 322- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Also stated in: § Influence of neoadjuvant chemoradiation on body composition and muscle strength · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“a lower number of stands during the 30 seconds chair stand test prior to nCRTx (hazard ratio 0.93, 95% confidence interval 0.87–0.99, P = 0.017)”
§ Influence of body composition and muscle strength on outcomes after multimodal oesophageal cancer treatment > Abstract > Results
plainstates an associationn = 322 ·- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Obesity did not significantly influence the incidence of other complications (data not shown).”
§ Influence of body composition and muscle strength on outcomes after multimodal oesophageal cancer treatment > Results > Influence of body composition and muscle strength on post‐operative complications
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
49 more claims
Create a free account to see all 89 claims and to verify the 48 references still open.
- It may state two separate claims as one. 26
- The quote only partly states this claim. 1
- Probably not a substantial claim. 16
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Influence of body composition and muscle strength on outcomes after multimodal oesophageal cancer treatment > Results > Influence of neoadjuvant chemoradiation on body composition and muscle strength
“−0.4 kg/m2”
§ Influence of body composition and muscle strength on outcomes after multimodal oesophageal cancer treatment > Results > Influence of neoadjuvant chemoradiation on body composition and muscle strength
“95% confidence interval (CI) −0.3 to 0.5”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Influence of body composition and muscle strength on outcomes after multimodal oesophageal cancer treatment > Results > Influence of body composition and muscle strength on long‐term survival
“visceral adipose tissue of >128 cm2 after nCRTx with impaired survival (hazard ratio 1.41, 95% CI 1.03–1.92, P = 0.34”
§ Influence of body composition and muscle strength on outcomes after multimodal oesophageal cancer treatment > Methods > Statistical analysis
“All tests were two‐sided, and P values less than 0.05 were considered significant.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“| N0 | 191 (59.5) | 79 (63.7) | 54 (54.0) | 0.131 | 93 (60) | 65 (58.0) | 0.944 | | N1 | 64 (19.9) | 27 (21.8) | 21 (21.0) | 0.131 | 91 (58.7) | 24 (21.4) | 0.944 | | N2–3 | 66 (20.5) | 18 (14.5) | 25 (25.0) | 0.131 | 31 (20.0) | 23 (20.5) | 0.944 |”
§ Influence of body composition and muscle strength on outcomes after multimodal oesophageal cancer treatment > Results > Patient characteristics
Reported 155 · recomputed 215
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“| R0 resection | 301 (94.1) | 114 (91.2) | 96 (96.0) | 0.151 | 145 (93.5) | 107 (62.2) | 0.405 |”
§ Influence of body composition and muscle strength on outcomes after multimodal oesophageal cancer treatment > Results > Patient characteristics
Reported 62.2 · recomputed 95.535714
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“| Total adipose tissue indexa (cm2/m2) | 106.2 ± 48.3 | 203.4 ± 54.7 | 0.692 | 97.9 ± 43.7 | 97.4 ± 53.1 | 0.924 |”
§ Influence of body composition and muscle strength on outcomes after multimodal oesophageal cancer treatment > Results > Relation between sarcopenia, body composition, and muscle strength
Reported 203.4 · recomputed 103.4
3 more findings
Create a free account to see every finding of this check.
Citations
Cites
Dindo, D., Demartines, N., & Clavien, P.-A. (2004) · Annals of Surgery · doi:10.1097/01.sla.0000133083.54934.ae · Cited by 31,378
Sarcopenia: European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Baeyens, J. P., Bauer, J. M., Boirie, Y., Cederholm, T., Landi, F., Martin, F. C., Michel, J.-P., Rolland, Y., Schneider, S. M., et al. (2010) · Age and Ageing · doi:10.1093/ageing/afq034 · Cited by 11,601
Elm, E. V., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., & Vandenbroucke, J. P. (2007) · BMJ · doi:10.1136/bmj.39335.541782.ad · Cited by 10,766
Definition and classification of cancer cachexia: an international consensus
Fearon, K., Strasser, F., Anker, S. D., Bosaeus, I., Bruera, E., Fainsinger, R. L., Jatoi, A., Loprinzi, C., MacDonald, N., Mantovani, G., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70218-7 · Cited by 5,767
Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
van Hagen, P., Hulshof, M. C. C. M., van Lanschot, J. J. B., Steyerberg, E. W., Henegouwen, M. I. V. B., Wijnhoven, B. P. L., Richel, D. J., Nieuwenhuijzen, G. A. P., Hospers, G. A. P., Bonenkamp, J. J., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1112088 · Cited by 5,521
Self-citationInflammatory Mechanisms in Obesity
Gregor, M. F., & Hotamisligil, G. S. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101322 · Cited by 3,754 · cited 1×
“Sarcopenia reduces physical activity, which leads to decreased energy and an increased risk of obesity.(15) When sarcopenia is accompanied by a high fat mass, it is called sarcopenic obesity.”
BackgroundPrado, C. M., Lieffers, J. R., McCargar, L. J., Reiman, T., Sawyer, M. B., Martin, L., & Baracos, V. E. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70153-0 · Cited by 3,238
Goodpaster, B. H., Park, S. W., Harris, T. B., Kritchevsky, S. B., Nevitt, M., Schwartz, A. V., Simonsick, E. M., Tylavsky, F. A., Visser, M., Newman, A. B., et al. (2006) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/61.10.1059 · Cited by 3,083 · cited 1×
“This suggests that not only the amount of muscle but also the quality of the muscle is of influence, and younger patients might have better muscle quality.(44,45)”
BackgroundA 30-s chair-stand test as a measure of lower body strength in community-residing older adults.
Jones, C. J., Rikli, R. E., & Beam, W. C. (1999) · Research Quarterly for Exercise and Sport · doi:10.1080/02701367.1999.10608028 · Cited by 2,921
Martin, L., Birdsell, L., MacDonald, N., Reiman, T., Clandinin, M. T., McCargar, L. J., Murphy, R., Ghosh, S., Sawyer, M. B., & Baracos, V. E. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.2722 · Cited by 2,680
Shapiro, J., van Lanschot, J. J. B., Hulshof, M. C. C. M., van Hagen, P., van Berge Henegouwen, M. I., Wijnhoven, B. P. L., van Laarhoven, H. W. M., Nieuwenhuijzen, G. A. P., Hospers, G. A. P., Bonenkamp, J. J., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00040-6 · Cited by 2,565
Self-citationEvans, W. J., Morley, J. E., Argilés, J., Bales, C., Baracos, V., Guttridge, D., Jatoi, A., Kalantar-Zadeh, K., Lochs, H., Mantovani, G., et al. (2008) · Clinical Nutrition · doi:10.1016/j.clnu.2008.06.013 · Cited by 2,450
Mourtzakis, M., Prado, C. M. M., Lieffers, J. R., Reiman, T., McCargar, L. J., & Baracos, V. E. (2008) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h08-075 · Cited by 2,224 · cited 4×
“Studies show that CT scan quality influences measurements of surface areas on CT slices, especially portal phase and slice thickness.(30,55) Furthermore, we did not only focus on skeletal muscle surface or sarcopenia, but we also focused on other parameters of body composition and muscle strength.”
BackgroundMethodInfluentialBiere, S. S., van Berge Henegouwen, M. I., Maas, K. W., Bonavina, L., Rosman, C., Garcia, J. R., Gisbertz, S. S., Klinkenbijl, J. H., Hollmann, M. W., de Lange, E. S., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60516-9 · Cited by 1,710
Self-citationShen, W., Punyanitya, M., Wang, Z., Gallagher, D., St.-Onge, M.-P., Albu, J., Heymsfield, S. B., & Heshka, S. (2004) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00744.2004 · Cited by 1,692 · cited 1×
“areas in this region are significantly related to whole-body composition.(29,30)”
BackgroundMitsiopoulos, N., Baumgartner, R. N., Heymsfield, S. B., Lyons, W., Gallagher, D., & Ross, R. (1998) · Journal of Applied Physiology · doi:10.1152/jappl.1998.85.1.115 · Cited by 1,522 · cited 1×
“adipose tissue were used to differentiate muscle and adipose tissue from other tissues.(31)”
MethodLow, D. E., Alderson, D., Cecconello, I., Chang, A. C., Darling, G. E., D'Journo, X. B., Griffin, S. M., Hölscher, A. H., Hofstetter, W. L., Jobe, B. A., et al. (2015) · Annals of Surgery · doi:10.1097/sla.0000000000001098 · Cited by 1,176
Self-citationSarcopenic Obesity Predicts Instrumental Activities of Daily Living Disability in the Elderly
Baumgartner, R. N., Wayne, S. J., Waters, D. L., Janssen, I., Gallagher, D., & Morley, J. E. (2004) · Obesity Research · doi:10.1038/oby.2004.250 · Cited by 937
Skeletal muscle loss: cachexia, sarcopenia, and inactivity
Evans, W. J. (2010) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2010.28608a · Cited by 723
The Obesity Paradox in Cancer: a Review
Lennon, H., Sperrin, M., Badrick, E., & Renehan, A. G. (2016) · Current Oncology Reports · doi:10.1007/s11912-016-0539-4 · Cited by 610
Effects of weight loss on regional fat distribution and insulin sensitivity in obesity.
Goodpaster, B. H., Kelley, D. E., Wing, R. R., Meier, A., & Thaete, F. L. (1999) · Diabetes · doi:10.2337/diabetes.48.4.839 · Cited by 608
Sarcopenic obesity: a critical appraisal of the current evidence
Prado, C. M. M., Wells, J. C. K., Smith, S. R., Stephan, B. C. M., & Siervo, M. (2012) · Clinical Nutrition · doi:10.1016/j.clnu.2012.06.010 · Cited by 589 · cited 1×
“as one of the most powerful independent predictors of poor survival for patients with cancer.(16,53) It should also be mentioned that handgrip strength is less reliable in older patients and the chair stand test can be influenced by co-morbidities.”
BackgroundEthical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle: update 2019
von Haehling, S., Morley, J. E., Coats, A. J. S., & Anker, S. D. (2019) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12501 · Cited by 389
Elliott, J. A., Doyle, S. L., Murphy, C. F., King, S., Guinan, E. M., Beddy, P., Ravi, N., & Reynolds, J. V. (2017) · Annals of Surgery · doi:10.1097/sla.0000000000002398 · Cited by 281
Tan, B. H. L., Brammer, K., Randhawa, N., Welch, N. T., Parsons, S. L., James, E. J., & Catton, J. A. (2015) · European Journal of Surgical Oncology (EJSO) · doi:10.1016/j.ejso.2014.11.040 · Cited by 277
Correa-de-Araujo, R., Harris-Love, M. O., Miljkovic, I., Fragala, M. S., Anthony, B. W., & Manini, T. M. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00087 · Cited by 268
Cachexia in patients with oesophageal cancer
Anandavadivelan, P., & Lagergren, P. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.200 · Cited by 262
The Importance of Body Composition in Explaining the Overweight Paradox in Cancer—Counterpoint
Caan, B. J., Cespedes Feliciano, E. M., & Kroenke, C. H. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-3287 · Cited by 224
Yip, C., Goh, V., Davies, A., Gossage, J., Mitchell-Hay, R., Hynes, O., Maisey, N., Ross, P., Gaya, A., Landau, D. B., et al. (2014) · European Radiology · doi:10.1007/s00330-014-3110-4 · Cited by 223
Tamandl, D., Paireder, M., Asari, R., Baltzer, P. A., Schoppmann, S. F., & Ba-Ssalamah, A. (2016) · European Radiology · doi:10.1007/s00330-015-3963-1 · Cited by 204
Nakashima, Y., Saeki, H., Nakanishi, R., Sugiyama, M., Kurashige, J., Oki, E., & Maehara, Y. (2018) · Annals of Surgery · doi:10.1097/sla.0000000000002252 · Cited by 196
Boshier, P. R., Heneghan, R., Markar, S. R., Baracos, V. E., & Low, D. E. (2018) · Diseases of the Esophagus · doi:10.1093/dote/doy047 · Cited by 164
Self-citationTrutschnigg, B., Kilgour, R. D., Reinglas, J., Rosenthall, L., Hornby, L., Morais, J. A., & Vigano, A. A. L. (2008) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h08-122 · Cited by 148
Reisinger, K. W., Bosmans, J. W. A. M., Uittenbogaart, M., Alsoumali, A., Poeze, M., Sosef, M. N., & Derikx, J. P. M. (2015) · Annals of Surgical Oncology · doi:10.1245/s10434-015-4558-4 · Cited by 127
Impact of Cancer, Type, Site, Stage and Treatment on the Nutritional Status of Patients
Bozzetti, F., Migliavacca, S., Scotti, A., BONALUML, M. G., Scarpa, D., Baticci, F., Ammatuna, M., Pupa, A., TERNO, G., Sequeira, C., et al. (1982) · Annals of Surgery · doi:10.1097/00000658-198208000-00009 · Cited by 117
Grotenhuis, B. A., Shapiro, J., van Adrichem, S., de Vries, M., Koek, M., Wijnhoven, B. P. L., & van Lanschot, J. J. B. (2016) · World Journal of Surgery · doi:10.1007/s00268-016-3603-1 · Cited by 109
Antoun, S., Bayar, A., Ileana, E., Laplanche, A., Fizazi, K., di Palma, M., Escudier, B., Albiges, L., Massard, C., & Loriot, Y. (2015) · European Journal of Cancer · doi:10.1016/j.ejca.2015.07.042 · Cited by 97
Age-related change in handgrip strength in men and women: is muscle quality a contributing factor?
Abe, T., Thiebaud, R. S., & Loenneke, J. P. (2016) · AGE · doi:10.1007/s11357-016-9891-4 · Cited by 76
Body composition measurement using computed tomography: Does the phase of the scan matter?
Rollins, K. E., Javanmard-Emamghissi, H., Awwad, A., Macdonald, I. A., Fearon, K. C. H., & Lobo, D. N. (2017) · Nutrition · doi:10.1016/j.nut.2017.02.011 · Cited by 76
Preoperative physical activity levels and postoperative pulmonary complications post-esophagectomy
Feeney, C., Reynolds, J. V., & Hussey, J. M. (2011) · Diseases of the Esophagus · doi:10.1111/j.1442-2050.2010.01171.x · Cited by 73
Straatman, J., van der Wielen, N., Nieuwenhuijzen, G. A. P., Rosman, C., Roig, J. M., Scheepers, J. J. G., Cuesta, M. A., Luyer, M. D. P., Henegouwen, M. I. V. B., van Workum, F., et al. (2016) · Surgical Endoscopy · doi:10.1007/s00464-016-4938-2 · Cited by 71
Self-citationBlom, R. L. G. M., Lagarde, S. M., Klinkenbijl, J. H. G., Busch, O. R., & Henegouwen, M. I. V. B. (2011) · Annals of Surgical Oncology · doi:10.1245/s10434-011-2103-7 · Cited by 65
Van Rijssen, L. B., van Huijgevoort, N. C. M., Coelen, R. J. S., Tol, J. A., Haverkort, E. B., Nio, C. Y., Busch, O. R., & Besselink, M. G. (2017) · Annals of Surgical Oncology · doi:10.1245/s10434-016-5495-6 · Cited by 58
Metabolic risk factors and ovarian cancer in the Metabolic Syndrome and Cancer project
Bjorge, T., Lukanova, A., Tretli, S., Manjer, J., Ulmer, H., Stocks, T., Selmer, R., Nagel, G., Almquist, M., Concin, H., et al. (2011) · International Journal of Epidemiology · doi:10.1093/ije/dyr130 · Cited by 47
The impact of obesity on esophagectomy: a meta-analysis
Mengardo, V, Pucetti, F., Mc Cormack, O., Chaudry, A., & Allum, W. H. (2018) · Diseases of the Esophagus · doi:10.1093/dote/dox149 · Cited by 44
Lee, J. S., Lee, H. S., Ha, J. S., Han, K. S., Rha, K. H., Hong, S. J., Chung, B. H., & Koo, K. C. (2018) · The Journal of Urology · doi:10.1016/j.juro.2018.01.069 · Cited by 43
Blom, R. L. G. M., Sosef, M. N., Nap, M., Lammering, G., van den Berkmortel, F., Hulshof, M. C. C. M., Meijer, S. L., Wilmink, H. W., & van Berge Henegouwen, M. I. (2014) · Diseases of the Esophagus · doi:10.1111/dote.12110 · Cited by 39
Self-citationSheetz, K. H., Zhao, L., Holcombe, S. A., Wang, S. C., Reddy, R. M., Lin, J., Orringer, M. B., & Chang, A. C. (2013) · Diseases of the Esophagus · doi:10.1111/dote.12020 · Cited by 29
Park, J. S., Cho, M. H., Nam, J. S., Ahn, C. W., Cha, B. S., Lee, E. J., Lim, S. K., Kim, K. R., & Lee, H. C. (2010) · Acta Diabetologica · doi:10.1007/s00592-009-0125-4 · Cited by 26
Guinan, E. M., Doyle, S. L., Bennett, A. E., O’Neill, L., Gannon, J., Elliott, J. A., O’Sullivan, J., Reynolds, J. V., & Hussey, J. (2017) · Supportive Care in Cancer · doi:10.1007/s00520-017-3993-0 · Cited by 24
CT-based assessment of visceral adiposity and outcomes for esophageal adenocarcinoma
Saeed, N., Shridhar, R., Almhanna, K., Hoffe, S. E., Chuong, M. D., & Meredith, K. L. (2017) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo.2017.07.03 · Cited by 12
Does neoadjuvant chemoradiotherapy increase survival in patients with resectable oesophageal cancer?
Buderi, S., Shackcloth, M. J., & Page, R. D. (2016) · Interactive Cardiovascular and Thoracic Surgery · doi:10.1093/icvts/ivw281 · Cited by 11
Implication of visceral obesity in patients with esophageal squamous cell carcinoma
Okamura, A., Watanabe, M., Yamashita, K., Yuda, M., Hayami, M., Imamura, Y., & Mine, S. (2017) · Langenbeck's Archives of Surgery · doi:10.1007/s00423-017-1643-0 · Cited by 6
Deng, H.-Y., Qin, C.-L., Qiu, X.-M., & Zhou, Q. (2018) · Interactive CardioVascular and Thoracic Surgery · doi:10.1093/icvts/ivx403 · Cited by 6
Muscle Strength Is Associated With Muscle Mass in Patients With Esophageal Cancer Awaiting Surgery
van Egmond, M. A., van der Schaaf, M., Hagens, E. R. C., van Laarhoven, H. W. M., van Berge Henegouwen, M. I., Haverkort, E. B., Engelbert, R. H. H., & Gisbertz, S. S. (2020) · Journal of Geriatric Physical Therapy · doi:10.1519/jpt.0000000000000200 · Cited by 5
Self-citation
Research works printed but not linked: 1
- Boer Maureen M, 2011, Herziene richtlijn ‘Oesofaguscarcinoom’, Ned Tijdschr Geneeskd, 155, A3732
Cited by
Jogiat, U., Sasewich, H., Turner, S. R., Baracos, V. E., Eurich, D. T., Filafilo, H., & Bédard, E. L. R. (2022) · Annals of Surgery · doi:10.1097/sla.0000000000005452 · Cited by 87
Jogiat, U., Bédard, E. L. R., Sasewich, H., Turner, S. R., Eurich, D. T., Filafilo, H., & Baracos, V. E. (2022) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13082 · Cited by 71
Song, M., Zhang, Q., Tang, M., Zhang, X., Ruan, G., Zhang, X., Zhang, K., Ge, Y., Yang, M., Li, Q., et al. (2021) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12778 · Cited by 71
Adiposity and cancer survival: a systematic review and meta-analysis
Cheng, E., Kirley, J., Feliciano, E. M. C., & Caan, B. J. (2022) · Cancer Causes & Control · doi:10.1007/s10552-022-01613-7 · Cited by 66
Halliday, L. J., Boshier, P. R., Doganay, E., Wynter-Blyth, V., Buckley, J., & Moorthy, K. (2022) · Diseases of the Esophagus · doi:10.1093/dote/doac046 · Cited by 63
Self-citation
Metadata
- Authors
- Hagens, E. R. C., Feenstra, M. L., van Egmond, M. A., van Laarhoven, H. W. M., Hulshof, M. C. C. M., Boshier, P. R., Low, D. E., van Berge Henegouwen, M. I., & Gisbertz, S. S.
- Affiliations
- Amsterdam University Medical Centers (NL)
- Virginia Mason Medical Center (US)
- Department of Surgery Amsterdam University Medical Centers, University of Amsterdam, Cancer Center Amsterdam Amsterdam The Netherlands
- Corresponding author
- Gisbertz, Suzanne S.
- ORCID
- Venue
- Journal of Cachexia, Sarcopenia and Muscle
- Publisher
- Wiley
- Published
- 2020-02-25
- Volume
- 11
- Issue
- 3
- Pages
- 756-767
- ISSN
- 2190-5991 (ISSN-L)
- 2190-6009
- PMC
- PMC7296271
- OpenAlex
- W3007363454
- Cited by
- 65
- References
- 55
- Citations by year
- 2026: 13 · 2025: 9 · 2024: 13 · 2023: 6 · 2022: 17 · 2021: 5 · 2020: 2
- FWCI
- 4.06
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Cachexia Sarcopenia and Muscle (publishedVersion, cc-by-nc-nd)
- Pure Amsterdam UMC (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Spiral (Imperial College London) (submittedVersion, other-oa)
- Funders
- Cancer Research UK (27981)
- National Institute for Health and Care Research (ACF-2014-21-007, CL-2017-21-005)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Medicine › Surgery › Esophageal Cancer Research and Treatment
- Health Sciences › Medicine › Oncology › Gastric Cancer Management and Outcomes
- Keywords
- esophageal cancer, sarcopenia, body composition, muscle strength, neoadjuvant chemoradiotherapy, visceral adipose tissue, subcutaneous adipose tissue, grip strength, chair stand test, anastomotic leakage, postoperative morbidity, overall survival, body mass index, esophagectomy, skeletal muscle area, maximal inspiratory pressure
- MeSH terms
- Body Composition, Esophageal Neoplasms, Female, Humans, Middle Aged, Retrospective Studies, Treatment Outcome, Muscle Strength
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-21, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-21 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.